Publicacións en colaboración con investigadores/as de Pitié-Salpêtrière Hospital (15)

2024

  1. Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip), Pisa, Italy, 28–29 September 2023

    Annales d'Endocrinologie

  2. Risk loci involved in giant cell arteritis susceptibility: a genome-wide association study

    The Lancet Rheumatology, Vol. 6, Núm. 6, pp. e374-e383

2023

  1. Economic evaluation of restrictive vs. liberal transfusion strategy following acute myocardial infarction (REALITY): trial-based cost-effectiveness and cost-utility analyses

    European heart journal. Quality of care & clinical outcomes, Vol. 9, Núm. 2, pp. 194-202

2022

  1. Proceedings of the annual meeting of the European Consortium of Lipodystrophies (ECLip) Cambridge, UK, 7–8 April 2022

    Annales d'Endocrinologie

2020

  1. Proportion of High-Risk/Very High-Risk Patients in Europe with Low-Density Lipoprotein Cholesterol at Target According to European Guidelines: A Systematic Review

    Advances in Therapy, Vol. 37, Núm. 5, pp. 1724-1736

2017

  1. A Genome-wide Association Study Identifies Risk Alleles in Plasminogen and P4HA2 Associated with Giant Cell Arteritis

    American Journal of Human Genetics, Vol. 100, Núm. 1, pp. 64-74

  2. Raltegravir 1200 mg once daily versus raltegravir 400 mg twice daily, with tenofovir disoproxil fumarate and emtricitabine, for previously untreated HIV-1 infection: a randomised, double-blind, parallel-group, phase 3, non-inferiority trial

    The Lancet HIV, Vol. 4, Núm. 11, pp. e486-e494

2016

  1. Monomorphic ventricular tachycardia in patients with Brugada syndrome: A multicenter retrospective study

    Heart Rhythm, Vol. 13, Núm. 3, pp. 669-682

  2. Prognostic significance of anaemia in patients with heart failure with preserved and reduced ejection fraction: Results from the MAGGIC individual patient data meta-analysis

    QJM, Vol. 109, Núm. 6, pp. 377-382

  3. The role of tenofovir alafenamide in future HIV management

    HIV Medicine, Vol. 17, pp. 4-16

2014

  1. Opportunistic infections and AIDS malignancies early after initiating combination antiretroviral therapy in high-income countries

    AIDS, Vol. 28, Núm. 16, pp. 2461-2473

2013

  1. 2013 ESC guidelines on the management of stable coronary artery disease

    European Heart Journal, Vol. 34, Núm. 38, pp. 2949-3003

2009

  1. Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial

    The Lancet, Vol. 374, Núm. 9704, pp. 1840-1848

  2. Lipoatrophy in GH deficient patients treated with a long-acting pegylated GH

    European Journal of Endocrinology, Vol. 161, Núm. 4, pp. 533-540

2005

  1. Adherence to guidelines is a predictor of outcome in chronic heart failure: The MAHLER survey

    European Heart Journal, Vol. 26, Núm. 16, pp. 1653-1659